Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Jette W. Sen"'
Autor:
Johan Lantto, Michael Kragh, Mikkel W. Pedersen, Ivan D. Horak, Christina R. Andersen, Bolette Bjerregaard, Dietmar Weilguny, Jette W. Sen, Klaus Koefoed, Ida Kjær, Anna Dahlman, Thomas T. Poulsen, Helle J. Jacobsen
Supplementary Figures S1-8. Figure S1 - Analysis of nonlinear blending synergy for the pairs of antibodies that constitute Pan-HER. Figure S2 - In vitro comparison of Pan-HER and a combination of cetuximab, trastuzumab and MM-121. Figure S3 - In vivo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3070cce3b363e6339b7b3ea62fc19ee0
https://doi.org/10.1158/1078-0432.22457522.v1
https://doi.org/10.1158/1078-0432.22457522.v1
Autor:
Johan Lantto, Michael Kragh, Mikkel W. Pedersen, Ivan D. Horak, Christina R. Andersen, Bolette Bjerregaard, Dietmar Weilguny, Jette W. Sen, Klaus Koefoed, Ida Kjær, Anna Dahlman, Thomas T. Poulsen, Helle J. Jacobsen
Supplementary Methods. Description of methods used for assessment of synergy, immunohistochemistry, cell death, cell cycle arrest, ADCC and CDC.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::613b15db10e954d8709624ee366dd4b8
https://doi.org/10.1158/1078-0432.22457519.v1
https://doi.org/10.1158/1078-0432.22457519.v1
Autor:
Johan Lantto, Michael Kragh, Mikkel W. Pedersen, Ivan D. Horak, Christina R. Andersen, Bolette Bjerregaard, Dietmar Weilguny, Jette W. Sen, Klaus Koefoed, Ida Kjær, Anna Dahlman, Thomas T. Poulsen, Helle J. Jacobsen
Supplementary Tables S1-2. Table S1 - Source, origin, subtype and growth medium for each cell line. Table S2 - Characteristics of tested patient-derived xenograft models.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::375612fd610b86cb208abe84d726cc97
https://doi.org/10.1158/1078-0432.22457516.v1
https://doi.org/10.1158/1078-0432.22457516.v1
Autor:
Johan Lantto, Michael Kragh, Mikkel W. Pedersen, Ivan D. Horak, Christina R. Andersen, Bolette Bjerregaard, Dietmar Weilguny, Jette W. Sen, Klaus Koefoed, Ida Kjær, Anna Dahlman, Thomas T. Poulsen, Helle J. Jacobsen
Purpose: Accumulating evidence indicates a high degree of plasticity and compensatory signaling within the human epidermal growth factor receptor (HER) family, leading to resistance upon therapeutic intervention with HER family members.Experimental D
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::33475f6437c82fd198f9e199000933c9
https://doi.org/10.1158/1078-0432.c.6523604
https://doi.org/10.1158/1078-0432.c.6523604
Publikováno v:
Biotechnology and bioengineering. 113(2)
Therapeutic monoclonal antibodies (mAbs) are mainly produced by heterologous expression in Chinese hamster ovary (CHO) cells. The glycosylation profile of the mAbs has major impact on the efficacy and safety of the drug and is therefore an important
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::0c997708cdd9aaab47c71edf0d2396b6
https://pubmed.ncbi.nlm.nih.gov/26222761
https://pubmed.ncbi.nlm.nih.gov/26222761
Publikováno v:
Analytical Chemistry. 75:1196-1202
Disease-specific alterations in proteins and peptides such as the appearance of new isoforms, changed relative concentrations of known isoforms, or changed catabolism characterize the group of protein precipitation disorders collectively known as amy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3c204a6a3b3369ac863444c3e2150c56
https://doi.org/10.1021/ac026174b
https://doi.org/10.1021/ac026174b
Autor:
María J. Hernáiz, Robert J. Linhardt, Niels H. H. Heegaard, Jette W. Sen, Yi Wu, Laurie A. LeBrun
Publikováno v:
European Journal of Biochemistry. 269:2860-2867
Synthetic peptides based on amino-acid residues 27-38 of human serum amyloid P component represent a novel type of heparin binders as they do not contain clusters of basic amino acids or other known features associated with protein or peptide heparin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b85f4058dc9ac6a7d6699a7563d914f6
https://doi.org/10.1046/j.1432-1033.2002.02964.x
https://doi.org/10.1046/j.1432-1033.2002.02964.x
Publikováno v:
Journal of Chromatography A. 894:319-327
The amyloidogenic protein beta-microglobulin was characterized by affinity capillary electrophoresis (CE). CE could separate conformational variants of beta2-microglobulin and with the amyloid-specific dye Congo red as a buffer additive it was possib
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::88e334673a1267a865393c9f2cba5231
https://doi.org/10.1016/s0021-9673(00)00579-3
https://doi.org/10.1016/s0021-9673(00)00579-3
Publikováno v:
Methods in molecular biology (Clifton, N.J.). 446
Tyrosine O-sulfation was first described about 50 years ago as a post-translational modification of fibrinogen. In the following 30 years it was considered to be a rare modification affecting only a few proteins and peptides. However, in the beginnin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::30c8da20e39d2f11ce372a699f778834
https://pubmed.ncbi.nlm.nih.gov/18373249
https://pubmed.ncbi.nlm.nih.gov/18373249
Publikováno v:
Methods in Molecular Biology™ ISBN: 9781588297198
Springer Protocols Handbooks ISBN: 9781603274746
Springer Protocols Handbooks ISBN: 9781603274746
Tyrosine O-sulfation was first described about 50 years ago as a post-translational modification of fibrinogen. In the following 30 years it was considered to be a rare modification affecting only a few proteins and peptides. However, in the beginnin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::890256b4ef47adcd0042c2f25b2922cf
https://doi.org/10.1007/978-1-60327-084-7_4
https://doi.org/10.1007/978-1-60327-084-7_4